• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antibiotics for Travellers' Diarrhoea on Trial-is there a potential role for Rifamycin SV?

作者信息

Riddle Mark S, Connor Patrick, Tribble David R

机构信息

Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, USA.

Research and Clinical Innovation, Royal Centre for Defence Medicine, Birmingham, UK.

出版信息

J Travel Med. 2019 Jan 1;26(1). doi: 10.1093/jtm/tay137.

DOI:10.1093/jtm/tay137
PMID:30476231
Abstract
摘要

相似文献

1
Antibiotics for Travellers' Diarrhoea on Trial-is there a potential role for Rifamycin SV?用于旅行者腹泻试验的抗生素——利福霉素SV有潜在作用吗？
J Travel Med. 2019 Jan 1;26(1). doi: 10.1093/jtm/tay137.
2
When should travel medicine practitioners prescribe Rifamycin SV-MXX for self-treatment of travellers' diarrhoea?旅行医学从业者应在何时开利福霉素SV-MXX用于旅行者腹泻的自我治疗？
J Travel Med. 2019 May 10;26(3). doi: 10.1093/jtm/taz013.
3
Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers' diarrhoea: reply.利福霉素SV-MMX®作为中度至重度旅行者腹泻的推荐自我治疗药物：回复
J Travel Med. 2019 May 10;26(3). doi: 10.1093/jtm/taz014.
4
Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria.利福昔明 MMX 治疗旅行者腹泻：与环丙沙星同样有效，且不与耐药菌的产生相关。
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay116.
5
In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK.利福昔明对从返回英国的旅行者中分离出的临床大肠杆菌和其他肠致病性细菌的体外活性。
Int J Antimicrob Agents. 2014 May;43(5):431-7. doi: 10.1016/j.ijantimicag.2014.01.026. Epub 2014 Mar 1.
6
Development of a new travellers' diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy.旅行者腹泻临床严重程度新分类的制定及其在确认利福昔明疗效中的应用。
J Travel Med. 2023 Oct 31;30(6). doi: 10.1093/jtm/taad043.
7
Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea.综述文章：利福昔明，一种极少被吸收的口服抗菌药物，用于治疗旅行者腹泻。
Aliment Pharmacol Ther. 2010 Jun;31(11):1155-64. doi: 10.1111/j.1365-2036.2010.04296.x. Epub 2010 Mar 11.
8
Systematic review: the epidemiology and clinical features of travellers' diarrhoea.系统评价：旅行者腹泻的流行病学和临床特征。
Aliment Pharmacol Ther. 2009 Aug;30(3):187-96. doi: 10.1111/j.1365-2036.2009.04028.x. Epub 2009 Apr 21.
9
Travellers' diarrhoea: contemporary approaches to therapy and prevention.旅行者腹泻：当代治疗与预防方法
Drugs. 2006;66(3):303-14. doi: 10.2165/00003495-200666030-00003.
10
Systematic review: prevention of travellers' diarrhoea.系统评价：旅行者腹泻的预防
Aliment Pharmacol Ther. 2008 May;27(9):741-51. doi: 10.1111/j.1365-2036.2008.03647.x. Epub 2008 Feb 14.

引用本文的文献

1
Development and Research Progress of Anti-Drug Resistant Bacteria Drugs.抗耐药菌药物的研发进展
Infect Drug Resist. 2021 Dec 21;14:5575-5593. doi: 10.2147/IDR.S338987. eCollection 2021.
2
Antimicrobial Resistance in the Asia Pacific region: a meeting report.亚太地区的抗微生物药物耐药性：会议报告。
Antimicrob Resist Infect Control. 2019 Dec 18;8:202. doi: 10.1186/s13756-019-0654-8. eCollection 2019.